The Cross-Border Biotech Blog

Biotechnology, Health and Business in Canada, the United States and Worldwide

Biotech Financings: Preview of 2010 Data Shows Momentum for 2011

The ‘2010 Canadian Healthcare Review’, which I co-author with James Smith, Vice President Healthcare at The Equicom Group, will be published in about two weeks. One of the components of this review is a summary of the financings by public Canadian healthcare companies.

Equity and convertible debt financings by public Canadian healthcare companies totaled $866.9 million in 2010. This financing number does not include debt, warrant exercises, license fees and milestones, and government grants. When financings by larger profitable companies are subtracted from this amount, financings by development stage companies in 2010 totaled $529.7 million, slightly higher than the $498.2 million raised during 2009.

The Q4 total of $259.3 million was almost half of the total raised in 2010, providing some momentum going into 2011.

About these ads

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

Follow

Get every new post delivered to your Inbox.

Join 129 other followers